Journal of clinical oncology (JCO) |
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial. |
sep. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study |
juil. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9). |
mar. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial |
Jan. 16 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer. |
oct. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial |
aoû. 16 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database. |
avr. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma. |
Jan. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study. |
Jan. 16 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database |
nov. 15 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study. |
fév. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer |
nov. 15 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
National Trends in Nonoperative Management of Rectal Adenocarcinoma. |
juin. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial |
Jan. 18 |
3 ♥ |
Cancers autres |
Journal of clinical oncology (JCO) |
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer |
nov. 15 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. |
juin. 16 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer |
nov. 15 |
4 ♥ |
Endoscopie/Imagerie, Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database. |
fév. 18 |
3 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial. |
mar. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Hepatology |
Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care |
mai. 19 |
4 ♥ |
Foie |
Journal of Hepatology |
Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. |
déc. 16 |
4 ♥ |
Foie |
Journal of Hepatology |
Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3 |
Jan. 19 |
3 ♥ |
Foie |
Journal of Hepatology |
EASL Clinical Practice Guidelines on the management of benign liver tumours☆ |
aoû. 16 |
4 ♥ |
Foie |